Candida endocarditis: Role of new antifungal agents

Mycoses

Volumn 52, Issue 1, 2009, Pages 60-66

  Talarmin, J P ^b   Boutoille, D ^b   Tattevin, P ^c   Abgueguen, P ^d   Ansart, S ^e   Roblot, F ^f   Raffi, F ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b HÔTEL DIEU   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

^f POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Candida albicans; Candida parapsilosis; Echinocandin; Fungal endocarditis; Pacemaker endocarditis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ADULT; AGED; ANEMIA; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOCARDITIS; FRANCE; HEART VALVE REPLACEMENT; HUMAN; LOADING DRUG DOSE; LONG TERM CARE; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; ECHINOCANDINS; ENDOCARDITIS; FATAL OUTCOME; FEMALE; FRANCE; HEART VALVE DISEASES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; YOUNG ADULT;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS;

EID: 57649219308     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01533.x     Document Type: Article

References (21)

1. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest 2002 122 : 302 10.
2. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001 32 : 50 62.
3. Pappas PG, Rex JH, Sobel JD et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004 38 : 161 89.
4. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000 30 : 633 8.
5. Clinical and Laboratory Standards Institute/National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. 2nd edn. CLSI/NCCLS document M27-A2 [ISBN 1-56238-469-4]. Clinical and Laboratory Standards Institute/NCCLS, Wayne, PA, USA, 2002.
6. Colombo AL, Barchiesi F, McGough DA, Rinaldi MG. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J Clin Microbiol 1995 33 : 535 40.
7. Clancy CJ, Nguyen MH. Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia. Antimicrob Agents Chemother 1999 43 : 1289 90.
8. Morace G, Amato G, Bistoni F et al. Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol 2002 40 : 2953 8.
9. Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J Clin Microbiol 2003 41 : 1440 6.
10. Chang HC, Chang JJ, Chan SH et al. Evaluation of Etest for direct antifungal susceptibility testing of yeasts in positive blood cultures. J Clin Microbiol 2001 39 : 1328 33.
11. Rex JH, Pfaller MA, Galgiani JN et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis 1997 24 : 235 47.
12. Pfaller MA, Messer SA, Boyken L, Huynh H, Hollis RJ, Diekema DJ. In vitro activities of 5-fluorocytosine against 8803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob Agents Chemother 2002 46 : 3518 21.
13. Pfaller MA, Diekema DJ, Rex JH et al. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 2006 44 : 819 26.
14. Steinbach WJ, Perfect JR, Cabell CH et al. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect 2005 51 : 230 47.
15. Bachmann SP, VandeWalle K, Ramage G et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002 46 : 3591 6.
16. Bacak V, Biocina B, Starcevic B, Gertler S, Begovac J. Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient - case report and review of literature. J Infect 2006 53 : e11 4.
17. Jimenez-Exposito MJ, Torres G, Baraldes A et al. Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment. Clin Infect Dis 2004 39 : e70 3.
18. Rajendram R, Alp NJ, Mitchell AR, Bowler IC, Forfar JC. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. Clin Infect Dis 2005 40 : e72 4.
19. Diekema DJ, Messer SA, Hollis RJ, Wenzel RP, Pfaller MA. An outbreak of Candida parapsilosis prosthetic valve endocarditis. Diagn Microbiol Infect Dis 1997 29 : 147 53.
20. Darwazah A, Berg G, Faris B. Candida parapsilosis: an unusual organism causing prosthetic heart valve infective endocarditis. J Infect 1999 38 : 130 1.
21. Joly V, Belmatoug N, Leperre A et al. Pacemaker endocarditis due to Candida albicans: case report and review. Clin Infect Dis 1997 25 : 1359 62.